Sales Representative (Medical and Pharmaceutical Products) Visa Pathway to Australia: Complete 2026 Guide
Updated: 16 June 2026
Australia classifies Sales Representative (Medical and Pharmaceutical Products) under ANZSCO 225412. VETASSESS conducts the skills assessment. The occupation sits on the Core Skills Occupation List (CSOL) but not the STSOL or MLTSSL, so the only available visas are the employer-sponsored 482 and 186. Typical 2026 salaries run AUD $90,000 to $176,000 including commission. Employer sponsorship is the sole route into this occupation.
Quick Facts: Sales Representative (Medical and Pharmaceutical Products) Migration Pathway
| Detail | Information |
|---|---|
| ANZSCO Code | 225412 (Sales Representative (Medical and Pharmaceutical Products)) |
| Skill Level | 1 (Bachelor degree or higher) |
| Skills Assessment | VETASSESS (Vocational Education and Training Assessment Services), Group B |
| Occupation List | CSOL only — not on the STSOL or MLTSSL |
| Visa Options | 482, 186 |
| Demand Level | Moderate to high — driven by pharma, medical-device and diagnostics companies |
| Salary Range | AUD $90,000-$176,000 including commission (SEEK / SalaryExpert, 2026) |
| Typical 189 Score | Not applicable — no points-tested pathway |
| Key Challenge | Employer sponsorship only; no 189, 190 or 491 route |
What Sales Representatives (Medical and Pharmaceutical Products) Do in Australia
A Sales Representative (Medical and Pharmaceutical Products) sells prescription medicines, medical devices, diagnostic equipment, dental and veterinary products to healthcare professionals and institutions. The audience is technical, made up of doctors, pharmacists, hospital procurement teams and specialists. The job blends scientific literacy with relationship selling. A representative must explain clinical data, stay current on a therapeutic area or device category, and work within strict promotional rules set by the regulator and industry codes.
Demand sits with the multinational pharmaceutical companies, medical-device firms and diagnostics suppliers concentrated in Sydney and Melbourne, where most Australian head offices and distribution operations are based. Roles often align to a therapeutic area such as oncology, cardiology or diabetes, and a science or health background helps a candidate earn clinician trust. VETASSESS draws a firm line here: the role must require significant technical product knowledge, which rules out front-line retail and call-centre positions.
The work is governed by strict rules. Pharmaceutical promotion in Australia operates under the Medicines Australia Code of Conduct and Therapeutic Goods Administration regulation, which set out what a representative may claim and how they may interact with prescribers. A good representative learns the clinical evidence behind a product, keeps records of every interaction, and stays inside those boundaries while still building a relationship with busy clinicians. Territory roles involve regular travel to hospitals, specialist rooms and pharmacies, often structured around a defined call cycle. Key-account roles add tender management and engagement with hospital formulary committees. This regulated, science-led selling is what the skills assessment expects to see documented.
ANZSCO 225412: Code Mapping
ANZSCO 225412 belongs to unit group 2254 Technical Sales Representatives. It covers a professional who sells medical, dental, veterinary and pharmaceutical products to healthcare professionals and establishments, applying technical and clinical product knowledge.
Core tasks include identifying and visiting prospective and existing clients, presenting product and clinical information, keeping current on the employer's and competitors' products, assessing customer needs, and providing after-sales technical support. If your products are industrial rather than medical, use 225411 Sales Representative (Industrial Products). If your technical goods fit neither specific category, the fallback is 225499 Technical Sales Representatives nec. Choose the code that matches the products you actually sell, because the assessment turns on documented duties.
Skills Assessment: VETASSESS
Sales Representative (Medical and Pharmaceutical Products) is assessed by VETASSESS as a Group B professional occupation. Both your qualifications and your employment must pass.
Requirements
- A qualification assessed as comparable to an AQF Bachelor degree or higher in a highly relevant field, such as science, pharmacy, biomedical science or marketing.
- At least one year of post-qualification employment at an appropriate skill level within the last five years, highly relevant to the role.
- At least five years of relevant employment can substitute for the formal qualification where you lack a relevant degree.
Assessment cost: AUD $1,205.60 for the full skills assessment (fee set after the October 2025 CPI increase).
Processing time: Around 7 weeks standard. Priority processing costs an extra AUD $907.50 and returns an outcome in about 10 business days.
Common rejection reasons: Roles based in retail or call-centre settings where deep product knowledge was not required, and reference letters that describe order-taking rather than clinical and technical selling. VETASSESS specifically excludes front-line positions, so make the technical nature of the work explicit.
English proficiency is proven separately at the visa stage.
Visa Pathways for Sales Representatives (Medical and Pharmaceutical Products)
Because 225412 is on the CSOL only, there is no 189, 190 or 491 pathway. Both available visas are employer-sponsored.
Subclass 482 — Skills in Demand Visa
The primary route. An approved sponsor nominates you for a qualifying role.
- Visa fee: AUD $3,210 (Core Skills stream, primary applicant)
- Salary threshold: The Core Skills Income Threshold is AUD $76,515 until 30 June 2026, rising to AUD $79,499 from 1 July 2026. Your guaranteed salary must meet the threshold and the market rate.
- Duration: Up to four years
- Quirk: Medical and pharmaceutical sales base salaries usually sit comfortably above the threshold, which makes the Core Skills stream a reliable fit for senior representatives.
Subclass 186 — Employer Nomination Scheme
Permanent residency through employer sponsorship, via Direct Entry or the Temporary Residence Transition stream after time on a 482.
- Visa fee: AUD $4,910 (primary applicant)
- Eligibility constraint: Direct Entry requires a positive VETASSESS assessment and at least three years of relevant experience.
- Quirk: Multinationals with established Australian operations are experienced sponsors and frequently move staff from a 482 to permanent residency through the Temporary Residence Transition stream.
There is no points test for this occupation, so the SkillSelect EOI process used for independent and state-nominated visas does not apply.
State Nomination
State and territory programmes draw their occupation lists from the federal STSOL and MLTSSL, and 225412 is on neither. No state currently offers a 190 or 491 nomination pathway for this code. The employer-sponsored 482 and 186 are the only options. Confirm the current SOL position before assuming any nomination is available, since federal lists are reviewed periodically.
Salary and Employment Outlook
| Role | Typical Salary Range (2026) |
|---|---|
| Medical / Pharmaceutical Sales Representative (entry) | AUD $85,000-$100,000 |
| Pharmaceutical Sales Representative (mid-level) | AUD $100,000-$130,000 |
| Specialist / Key Account Representative | AUD $130,000-$176,000 |
Figures combine SEEK and SalaryExpert 2026 data and reflect total earnings, which include a meaningful commission and bonus component on top of base. Superannuation is paid at 11.5%, and a company vehicle or car allowance is standard given the territory travel. The highest earners work in specialised therapeutic areas, hospital and specialist sales, and senior key-account roles with the multinationals. Melbourne and Sydney lead on pay because the head offices and largest territories sit there.
The outlook is steady. Australia's ageing population, a continuing pipeline of new medicines, and growth in medical devices and diagnostics all support ongoing demand for representatives who can explain complex products to clinicians. Career progression typically runs from a general-practice or community territory, into hospital and specialist sales, and on to key-account management or sales-team leadership. Each step lifts both the base salary and the technical depth the role demands. For migrants, the senior end of this ladder matters, because the higher base salaries at specialist and key-account level clear the visa income threshold with room to spare, which makes those roles the cleanest fit for employer sponsorship.
Tips for a Successful Application
- Land the sponsor first. There is no state or independent route, so the process begins with a job offer from an approved sponsor. Multinationals are the most experienced sponsors in this field.
- Lean on your science background. A degree in science, pharmacy or biomedical science strengthens both the VETASSESS assessment and your credibility with clinicians. Document it clearly.
- Make the clinical selling explicit. VETASSESS excludes retail and call-centre roles. Have referees describe the therapeutic knowledge, clinical presentations and needs assessment that defined your work.
- Use the correct code. Medical and pharmaceutical goods sit under 225412; industrial goods under 225411. Selecting the wrong code is a common cause of a failed assessment.
- Map the route to permanent residency. If the 186 is the goal, agree the Temporary Residence Transition timeline with your sponsor before you start on the 482.
Step-by-Step Migration Roadmap
- Confirm your duties and products map to 225412 using the ANZSCO code finder.
- Verify 225412 remains on the CSOL for 2026.
- Secure a sponsoring employer and confirm the role meets the income threshold.
- Gather degree transcripts and reference letters that detail clinical and technical selling.
- Sit an English test to meet visa requirements.
- Lodge the VETASSESS skills assessment (AUD $1,205.60).
- Have the employer lodge the sponsorship and nomination.
- Apply for the subclass 482 visa.
- Complete health and character checks.
- Receive the grant and begin work.
- After the qualifying period, apply for the subclass 186 through the Temporary Residence Transition stream.
- Receive permanent residency.
Frequently Asked Questions
Can I migrate as a medical sales rep without an employer sponsor?
No. ANZSCO 225412 is on the Core Skills Occupation List only, with no place on the STSOL or MLTSSL. That removes the 189, 190 and 491 from the table. The only pathways are the employer-sponsored subclass 482 and the subclass 186, so a sponsoring employer is essential.
Do I need a science degree to pass the VETASSESS assessment?
Not strictly, but a relevant degree in science, pharmacy, biomedical science or marketing makes the assessment far stronger. Without a relevant qualification, you can rely on at least five years of relevant employment to substitute for the degree. Either way, your evidence must show genuine technical and clinical selling.
Does the salary threshold include my commission?
No. The Core Skills Income Threshold is measured against guaranteed annual earnings, not commission or bonuses. Medical and pharmaceutical base salaries usually clear the threshold comfortably, but confirm the fixed base meets AUD $76,515, rising to AUD $79,499 from 1 July 2026, before relying on the 482.
What is the demand outlook for medical sales reps in Australia in 2026?
Demand is steady to firm, supported by an ageing population, ongoing pharmaceutical launches and growth in medical devices and diagnostics. Roles remain concentrated with the multinationals in Sydney and Melbourne. Because migration runs entirely through employer sponsorship, your prospects track the willingness of those companies to sponsor international hires for specific therapeutic teams.
